Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar's(TM) Ability to Inhibit ...

Drug resistance is one of the greatest challenges in cancer treatment. Therefore, understanding its mechanisms is essential ...

On Crowncast, Enrico Pesenti explains how cancer drug resistance forms and how advanced technologies are helping researchers ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Lung cancer is the commonest cancer worldwide ... Some of these effects are through the tumor suppressor LKref-1. Hypoxic mechanisms of drug resistance in NSCLC Hypoxia contributes to chemotherapy ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance ...

The identification of new drug resistance mechanisms and prostate cancer molecular subtypes based on genomic and proteomic analysis, as well as prognostic and predictive biomarkers, may further ...

"Additionally, we aim to identify novel drugs that could target this mechanism and offer potential new treatments for castrate-resistant prostate cancer." ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer ...

Acquired resistance to doxorubicin significantly reduces its therapeutic efficacy, limiting its clinical use in breast cancer treatment. Pan-AKR1C inhibitors have demonstrated potential in restoring ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the ...